isabelobrien, Author at European Medical Journal - Page 34 of 66

Handshake on blue background

Novo Nordisk expands stem cell research arm with Evotec

Evotec has joined forces with Novo Nordisk to advance the clinical and commercial manufacturing of stem cell-based therapies.

Cracking compliance in the US: Key points for pharma to remember

What key compliance considerations should pharma companies keep in mind before releasing new research in the US market, and how can they avoid compliance pitfalls?

Moderna’s Chantal Friebertshäuser on improving vaccine confidence

The EMJ GOLD podcast is back! Our first guest is Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna.

US to donate 1 million mpox vaccines to Africa amid outbreak

In response to the ongoing mpox outbreak in parts of Africa, the US government has announced a significant donation of 1 million vaccines.

The rise, fall and smart allocation of pharma marketing budgets

This infographic shows how budgets have fluctuated over the years, and where to allocate remaining spend before the end of 2024.

Checklist

New ABPI Code of Practice includes updates from PMCPA

The 2024 edition of the ABPI’s Code of Practice was published today, including new procedures under the PMCPA.

Illustration of man administering vaccine to a woman

GSK pursues co-administration of RSV and shingles vaccines

New findings have been revealed on the co-administration of GSK’s RSV and existing shingles vaccine.

Finding the interactive edge in medical education

This infographic explores the rising demand for interactive content, highlighting its power to boost engagement, improve message retention and more.

Musk's vision implant gets FDA breakthrough device tag

Neuralink, Elon Musk’s brain-chip startup, has been given breakthrough device designation from the FDA for its experimental implant aimed at restoring vision.

contract

Warner Biddle takes top job at Kyverna Therapeutics

Warner Biddle has been appointed as CEO, Kyverna Therapeutics, following the resignation of Peter Maag this week.